# A Three-Part Study Of GSK580416 In Healthy Subjects

> **NCT00427141** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (actual)

## Conditions studied

- Respiratory Tract Infection
- Infections, Bacterial

## Interventions

- **DRUG:** GSK580416

## Key facts

- **NCT ID:** NCT00427141
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2012-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427141, "A Three-Part Study Of GSK580416 In Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00427141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*